Clinical Trial Protocol for prePSMA: A Multicenter, Randomized, Noninferiority Trial of Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography as Triage for Extended Pelvic Lymph Node Dissection in Patients Scheduled for Robot-assisted Laparoscopic Radical Prostatectomy.

Qvigstad LF; Aas K; Tulipan A; Hole KH; Storås AH; Hammarström C; Ghiasvand R; Holmedal SH; Berge V

doi:10.1016/j.euf.2025.07.010

← 뒤로

Clinical Trial Protocol for prePSMA: A Multicenter, Randomized, Noninferiority Trial of Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography as Triage for Extended Pelvic Lymph Node Dissection in Patients Scheduled for Robot-assisted Laparoscopic Radical Prostatectomy.

European urology focus 2025 Vol.11(6) p. 915-920

Qvigstad LF, Aas K, Tulipan A, Hole KH, Storås AH, Hammarström C, Ghiasvand R, Holmedal SH, Berge V

원문 ↗ DOI ↗ BibTeX ↓ RIS ↓

📝 환자 설명용 한 줄

🔬 핵심 임상 통계 (초록에서 자동 추출 — 원문 검증 권장)

연구 설계 randomized controlled trial

이 논문을 인용하기

BibTeX ↓ RIS ↓

APA Qvigstad LF, Aas K, et al. (2025). Clinical Trial Protocol for prePSMA: A Multicenter, Randomized, Noninferiority Trial of Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography as Triage for Extended Pelvic Lymph Node Dissection in Patients Scheduled for Robot-assisted Laparoscopic Radical Prostatectomy.. European urology focus, 11(6), 915-920. https://doi.org/10.1016/j.euf.2025.07.010

MLA Qvigstad LF, et al.. "Clinical Trial Protocol for prePSMA: A Multicenter, Randomized, Noninferiority Trial of Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography as Triage for Extended Pelvic Lymph Node Dissection in Patients Scheduled for Robot-assisted Laparoscopic Radical Prostatectomy.." European urology focus, vol. 11, no. 6, 2025, pp. 915-920.

PMID 40731245

DOI 10.1016/j.euf.2025.07.010

Abstract

prePSMA is a randomized controlled trial in which patients with high-risk prostate cancer and selected cases with intermediate-risk disease are randomized to a control arm in which all patients undergo extended pelvic lymph node dissection (ePLND), or an experimental arm in which ePLND is only performed in patients with positive preoperative findings on prostate-specific membrane antigen positron emission tomography/computed tomography.

MeSH Terms

Humans; Male; Equivalence Trials as Topic; Laparoscopy; Lymph Node Excision; Multicenter Studies as Topic; Pelvis; Positron Emission Tomography Computed Tomography; Preoperative Care; Prostatectomy; Prostatic Neoplasms; Robotic Surgical Procedures; Triage